English ticker view

PHAT

PHATHOM PHARMACEUTICALS INC

This page combines public comments, SEC 13F holdings, insider trades, and simple return calculations for one ticker. Use the original source links before making your own decision.

Full Korean data view Search another ticker

Current price

$11.93

Public comments

13F holding rows

Insider trade rows

Public comments

Ranked by current return where prices are available.

13F direction

25 / 20

New or increased positions vs reduced or sold positions.

Insider activity

0 buyers

Based on SEC Form 4 market purchase and sale rows.

Latest comments

Most recent public records

No public comment records are connected to this ticker yet.

SEC 13F

Institution holding changes

Nuveen Asset Management, LLC

decreased · Feb 14, 2025

+46.9%

Filing price $8.12 · Current $11.93

JPMorgan Chase & Co.

sold out · May 13, 2026

+13.3%

Filing price $10.53 · Current $11.93

Royal Bank of Canada

decreased · May 15, 2026

+7.5%

Filing price $11.0995 · Current $11.93

FMR LLC / Fidelity

decreased · May 15, 2026

+7.4%

Filing price $11.1092 · Current $11.93

Optiver Holding B.V.

unchanged · May 15, 2026

+7.4%

Filing price $11.1099 · Current $11.93

Mirae Asset Global Investments Co., Ltd.

increased · May 4, 2026

+7.4%

Filing price $11.11 · Current $11.93

Bank of New York Mellon Corp

increased · May 5, 2026

+7.4%

Filing price $11.11 · Current $11.93

UBS Asset Management Americas

increased · May 13, 2026

+7.4%

Filing price $11.11 · Current $11.93

Insider trades

SEC Form 4 summary

No insider summary is connected to this ticker yet.

Information only. WhenBuy summarizes public data and simple calculations. It is not a stock recommendation, and returns may not reflect dividends, taxes, FX rates, fees, splits, or exact trade timing.